News Roundup: August 28 to September 1
Your weekly roundup of the latest news from Drug Topics®.
Evaluating Pharmacist-Driven CGM Services in Community, Ambulatory Care Settings
Although investigators found a lack of strong evidence to support CGM programs in community pharmacy settings, studies in ambulatory care settings suggest that these programs are both feasible and beneficial.
Cannabis Effective at Reducing Symptoms in Children With Cancer, but More Research Needed
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
Filling Prescriptions for Pet Patients: Best Practices
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
Positive Results Announced From Phase 3 Study of PCSK9 Inhibitor for HeFH
LIB Therapeutics released data from the LIBerate-HeFH trial that showed lerodalcibep achieved statistically significant placebo adjusted reductions in mean LDL-C at Week 24 and at the mean of Weeks 22 and 24.
Don’t Get Caught Up With a HIPAA Violation
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
